Xi Li1,2, Ricardo Paz-Fumagalli3, Weiping Wang2, Beau B Toskich2, John A Stauffer4, Gregory T Frey2, J Mark McKinney2, Justin H Nguyen5. 1. Interventional Radiology Department, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guandong, China. 2. Division of Interventional Radiology, Mayo Clinic, Jacksonville, FL, 32224, USA. 3. Division of Interventional Radiology, Mayo Clinic, Jacksonville, FL, 32224, USA. paz.ricardo@mayo.edu. 4. Department of General Surgery, Mayo Clinic, Jacksonville, FL, USA. 5. Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA.
Abstract
BACKGROUND: This study evaluates preliminary results of image-guided percutaneous direct pancreatic duct intervention in the management of pancreatic fistula after surgery or pancreatitis when initially ineligible for surgical or endoscopic therapy. METHODS: Between 2001 and 2018 the medical records of all patients that underwent percutaneous pancreatic duct intervention for radiographically confirmed pancreatic fistula initially ineligible for surgical or endoscopic repair were reviewed for demographics, clinical history, procedure details, adverse events, procedure related imaging and laboratory results, ability to directly catheterized the main pancreatic duct, and whether desired clinical objectives were met. RESULTS: In 10 of 11patients (6 male and 5 female with mean age 60.5, range 39-89) percutaneous pancreatic duct cannulation was possible. The 10 duct interventions included direct ductal suction drainage in 7, percutaneous duct closure in 3 and stent placement in 1. Pancreatic fistulas closed in 7 of 10, 2 were temporized until elective surgery, and 1 palliated until death from malignancy. The single patient with failed duct cannulation resolved the fistula with prolonged catheter drainage of the peri-pancreatic cavity. There were no major adverse events related to intervention. CONCLUSION: In patients with pancreatic fistulas initially ineligible for endoscopic therapy or elective surgery, direct percutaneous pancreatic duct interventions are possible, can achieve improvement without major morbidity or mortality, and can improve and maintain the medical condition of patients in preparation for definitive surgery.
BACKGROUND: This study evaluates preliminary results of image-guided percutaneous direct pancreatic duct intervention in the management of pancreatic fistula after surgery or pancreatitis when initially ineligible for surgical or endoscopic therapy. METHODS: Between 2001 and 2018 the medical records of all patients that underwent percutaneous pancreatic duct intervention for radiographically confirmed pancreatic fistula initially ineligible for surgical or endoscopic repair were reviewed for demographics, clinical history, procedure details, adverse events, procedure related imaging and laboratory results, ability to directly catheterized the main pancreatic duct, and whether desired clinical objectives were met. RESULTS: In 10 of 11patients (6 male and 5 female with mean age 60.5, range 39-89) percutaneous pancreatic duct cannulation was possible. The 10 duct interventions included direct ductal suction drainage in 7, percutaneous duct closure in 3 and stent placement in 1. Pancreatic fistulas closed in 7 of 10, 2 were temporized until elective surgery, and 1 palliated until death from malignancy. The single patient with failed duct cannulation resolved the fistula with prolonged catheter drainage of the peri-pancreatic cavity. There were no major adverse events related to intervention. CONCLUSION: In patients with pancreatic fistulas initially ineligible for endoscopic therapy or elective surgery, direct percutaneous pancreatic duct interventions are possible, can achieve improvement without major morbidity or mortality, and can improve and maintain the medical condition of patients in preparation for definitive surgery.
Authors: Claudio Bassi; Giovanni Marchegiani; Christos Dervenis; Micheal Sarr; Mohammad Abu Hilal; Mustapha Adham; Peter Allen; Roland Andersson; Horacio J Asbun; Marc G Besselink; Kevin Conlon; Marco Del Chiaro; Massimo Falconi; Laureano Fernandez-Cruz; Carlos Fernandez-Del Castillo; Abe Fingerhut; Helmut Friess; Dirk J Gouma; Thilo Hackert; Jakob Izbicki; Keith D Lillemoe; John P Neoptolemos; Attila Olah; Richard Schulick; Shailesh V Shrikhande; Tadahiro Takada; Kyoichi Takaori; William Traverso; Charles R Vollmer; Christopher L Wolfgang; Charles J Yeo; Roberto Salvia; Marcus Buchler Journal: Surgery Date: 2016-12-28 Impact factor: 3.982
Authors: Ara B Sahakian; Preeth Jayaram; M Victoria Marx; Kazuhide Matsushima; Caroline Park; James L Buxbaum Journal: Gastrointest Endosc Date: 2017-08-24 Impact factor: 9.427
Authors: Shayan Irani; Michael Gluck; Andrew Ross; S Ian Gan; Robert Crane; John J Brandabur; Ellen Hauptmann; Mehran Fotoohi; Richard A Kozarek Journal: Gastrointest Endosc Date: 2012-09 Impact factor: 9.427
Authors: M Mutignani; A Tringali; E Khodadadian; L Petruzziello; C Spada; G Spera; P Familiari; G Costamagna Journal: Endoscopy Date: 2004-08 Impact factor: 10.093
Authors: T J Howard; C E Stonerock; J Sarkar; G A Lehman; S Sherman; E A Wiebke; J A Madura; T A Broadie Journal: Surgery Date: 1998-10 Impact factor: 3.982
Authors: Stefan Seewald; Boris Brand; Stefan Groth; Salem Omar; Gerardo Mendoza; Uwe Seitz; Ichiro Yasuda; He Xikun; Vo Chieu Nam; Hong Xu; Frank Thonke; Nib Soehendra Journal: Gastrointest Endosc Date: 2004-04 Impact factor: 9.427
Authors: Margaret G Keane; Shun Fung Sze; Natascha Cieplik; Sam Murray; Gavin J Johnson; George J Webster; Douglas Thorburn; Stephen P Pereira Journal: Surg Endosc Date: 2015-12-16 Impact factor: 4.584